RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+15.37%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$855M
AUM Growth
+$855M
(+32%)
Cap. Flow
+$145M
Cap. Flow
% of AUM
16.99%
Top 10 Holdings %
Top 10 Hldgs %
33.51%
Holding
104
New
21
Increased
54
Reduced
10
Closed
11
Top Buys
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$30.2M |
| 2 |
STJ
St Jude Medical
STJ
|
$21.8M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$9.57M |
| 4 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$9.5M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$8.91M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$13.2M |
| 2 |
Gilead Sciences
GILD
|
$10.2M |
| 3 |
Pacira BioSciences
PCRX
|
$9.89M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
$8.92M |
| 5 |
Cardinal Health
CAH
|
$6.91M |
Sector Composition
| 1 | Healthcare | 73.14% |
| 2 | Financials | 1.36% |
| 3 | Technology | 0.94% |
| 4 | Industrials | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $39.7M | 4.65% | 550,000 +22,500 | +4% | +$1.62M |
|
2
AbbVie
ABBV
$372B
| $38M | 4.44% | 580,000 +55,000 | +10% | +$3.6M |
|
|
COV
3
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $30.2M | 3.53% | +295,000 | New | +$30.2M |
|
4
HCA Healthcare
HCA
$94.5B
| $29.9M | 3.5% | 408,000 +87,750 | +27% | +$6.44M |
|
5
McKesson
MCK
$85.4B
| $29M | 3.39% | 139,750 +11,250 | +9% | +$2.34M |
|
6
Amgen
AMGN
$155B
| $25.6M | 3% | 161,000 +16,000 | +11% | +$2.55M |
|
7
Merck
MRK
$210B
| $25.6M | 2.99% | 450,000 -25,000 | -5% | -$1.42M |
|
|
8
Gilead Sciences
GILD
$140B
| $24M | 2.81% | 255,000 -108,000 | -30% | -$10.2M |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $22.7M | 2.65% | 88,000 +250 | +0.3% | +$64.4K |
|
|
STJ
10
DELISTED
St Jude Medical
STJ
| $21.8M | 2.55% | +335,000 | New | +$21.8M |
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $21.6M | 2.53% | 193,000 +27,000 | +16% | +$3.02M |
|
12
Acadia Healthcare
ACHC
$2.12B
| $20.2M | 2.36% | 329,750 +126,750 | +62% | +$7.76M |
|
|
AVNR
13
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $18.6M | 2.18% | 1,100,000 | – | – |
|
|
THOR
14
DELISTED
THORATEC CORPORATION
THOR
| $17.3M | 2.03% | 533,500 +12,500 | +2% | +$406K |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $17.1M | 2% | 92,500 +2,750 | +3% | +$509K |
|
16
Biogen
BIIB
$19.4B
| $15.4M | 1.81% | 45,500 -15,850 | -26% | -$5.38M |
|
|
TMH
17
DELISTED
Team Health Holdings Inc
TMH
| $15.3M | 1.79% | 266,500 +115,750 | +77% | +$6.66M |
|
18
CVS Health
CVS
$92.8B
| $14.4M | 1.69% | 150,000 +20,000 | +15% | +$1.93M |
|
19
Humana
HUM
$36.5B
| $13.8M | 1.62% | 96,250 +16,750 | +21% | +$2.41M |
|
|
AET
20
DELISTED
Aetna Inc
AET
| $11.6M | 1.36% | 131,000 +25,000 | +24% | +$2.22M |
|
|
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
| $11.6M | 1.35% | 675,000 -60,000 | -8% | -$1.03M |
|
|
EVHC
22
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $10.9M | 1.28% | 315,000 +29,500 | +10% | +$1.02M |
|
|
PCYC
23
DELISTED
PHARMACYCLICS INC
PCYC
| $10.8M | 1.27% | 88,500 +3,250 | +4% | +$397K |
|
|
HRC
24
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $10.3M | 1.2% | 225,000 +12,000 | +6% | +$547K |
|
|
OREX
25
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $10.2M | 1.19% | 1,685,000 +435,000 | +35% | +$2.64M |
|